Author:
Fu Luo-Qin,Wang Shi-Bing,Cai Mao-Hua,Wang Xue-Jun,Chen Jin-Yang,Tong Xiang-Min,Chen Xiao-Yi,Mou Xiao-Zhou
Funder
National Natural Science Foundation of China
Zhejiang Provincial Science and Technology Projects
Funds of Traditional Chinese Medicine Science and Technology Project of Zhejiang Province
Subject
Cancer Research,Infectious Diseases,Virology
Reference100 articles.
1. A novel chimeric oncolytic virus vector for improved safety and efficacy as a platform for the treatment of hepatocellular carcinoma;Abdullahi;J. Virol.,2018
2. Editorial: oncolytic virus and gene thearapy application: update 2018;Abei;Curr. Cancer Drug Targets,2018
3. PHOCUS: A phase 3 randomized, open-label study comparing the oncolytic immunotherapy Pexa-Vec followed by sorafenib (SOR) vs SOR in patients with advanced hepatocellular carcinoma (HCC) without prior systemic therapy;Abou-Alfa;J. Clin. Oncol.,2016
4. Brief communication; a heterologous oncolytic bacteria-virus prime-boost approach for anticancer vaccination in mice;Aitken;J Immunother,2018
5. Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports;Alberts;APMIS: acta pathologica, microbiologica, et immunologica Scandinavica,2016
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献